Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1395, 2012-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab/infliximab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. :
Access to resources
Recommend
Adalimumab/infliximab: First report of pseudolymphoma: case report
Reactions Weekly, Vol. 1, Iss. 1401, 2012-01 ,pp. :
Adalimumab/infliximab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. :
Adalimumab/infliximab: Pityriasis amiantacea: case report
Reactions Weekly, Vol. 1, Iss. 1419, 2012-01 ,pp. :
Adalimumab/infliximab: Dermatomyositis with fasciitis: case report
Reactions Weekly, Vol. 1, Iss. 1393, 2012-01 ,pp. :